Oncoloxía médica
Servizo
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (46)
2024
-
Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients
European Journal of Clinical Investigation
2023
-
Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section
Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 796-802
-
Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis
Clinical and Translational Oncology, Vol. 25, Núm. 4, pp. 941-958
2022
-
Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry
Biomedicines, Vol. 10, Núm. 1
-
Methods for the Detection of Circulating Biomarkers in Cancer Patients
Advances in experimental medicine and biology, Vol. 1379, pp. 525-552
-
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
European Journal of Cancer, Vol. 168, pp. 12-24
2021
-
Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies
Cancers, Vol. 13, Núm. 12
-
Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method
Healthcare (Switzerland), Vol. 9, Núm. 6
-
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study
European Journal of Cancer, Vol. 156, pp. 70-82
-
Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy
Cancer Immunology, Immunotherapy, Vol. 70, Núm. 5, pp. 1177-1188
-
Letter to the editor: “Liquid biopsy based on saliva cell-free DNA as a potential biomarker for head and neck cancer”
Oral Oncology
-
Saliva gene promoter hypermethylation as a biomarker in oral cancer
Journal of Clinical Medicine, Vol. 10, Núm. 9
-
Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part i: A diagnostic accuracy meta-analysis
Journal of Personalized Medicine, Vol. 11, Núm. 6
-
Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part ii: A cancer risk meta-analysis
Journal of Personalized Medicine, Vol. 11, Núm. 7
-
Trajectories of alcohol consumption during life and the risk of developing breast cancer
British Journal of Cancer, Vol. 125, Núm. 8, pp. 1168-1176
2020
-
Association of salivary human papillomavirus infection and oral and oropharyngeal cancer: A meta-analysis
Journal of Clinical Medicine, Vol. 9, Núm. 5
-
Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges
Frontiers in Oncology, Vol. 10
-
Global gene expression characterization of circulating tumor cells in metastasic castration-resistant prostate cancer patients
Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-14
-
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
The Lancet Oncology, Vol. 21, Núm. 11, pp. 1413-1422
-
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 38, Núm. 3, pp. 203-213